Menu
Back to Journals » Cancer Management and Research » Volume 13
SNHG1 Promotes Malignant Progression of Glioma by Targeting miR-140-5p and Regulating PI3K/AKT Pathway [Retraction]
Cai RD, Zhang CC, Xie LL, et al. Cancer Manag Res. 2020;12:12011–12020.
The Editor and Publisher of Cancer Management and Research wish to retract the published article. Concerns were raised over the flow cytometry data presented in the article and over alleged image duplication in Figures 2F, 3F and 6C, specifically:
- Figure 2F panel KNS-81 si-NC appears to show duplication with regions from panel KALS-1 si-NC.
- Figure 2F panel KNS-81 SNHG1 appears to show duplication with regions from panel KALS-1 SNHG1.
- Figure 3C panel KALS-1 miR-NC appears to show duplication with regions from Figure 6C panel KNS-81 si-NC.
The authors responded to our queries but were unable to provide a satisfactory reason for the alleged duplication and were unable to provide any original data for their study. The Editor advised for the paper to be retracted.
Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
© 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.